… as Chief Financial Officer, effective May 15, 2025. He will take over the CFO … , who had been serving as CFO on an interim basis since … . and Chief Financial Officer of AnaptysBio, Inc. Mr. Hoffman started his career at Arena Pharmaceuticals …

… impactful therapies,” said Laurie Stelzer, Chief Financial Officer of Kailera. “I’m … held CFO roles at ReNAgade Therapeutics, Mirati Therapeutics, and Arena Pharmaceuticals, where … President of Finance, Division CFO for the Regenerative Medicine Division …

… appointment of Aaron Ondrey, as Chief Financial Officer, and the further evolution of … Ondrey most recently served as CFO of Mirati Therapeutics through the … held senior leadership positions at Arena Pharmaceuticals, Alexion Pharmaceuticals, and Regeneron …

… Stelzer as Chief Financial Officer. Ms. Stelzer most recently served as Chief Financial Officer of … Previously, she served as CFO of Arena Pharmaceuticals, where she helped lead … President of Finance, Division CFO for the Regenerative Medicine Division …

… assume the role of interim CFO. Ms. Stelzer will remain … held senior leadership roles at Arena Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc. and … ;mirati-therapeutics-announces-departure-of-chief-financial-officer-laurie-stelzer-301908485.html SOURCE …

… ; Previously, Ms. Roberts served as Chief Financial Officer of Lineage Cell Therapeutics, Inc … Ms. Roberts previously served as Chief Financial Officer of Mast Therapeutics, Inc. from … formed in January 2020 by Arena Pharmaceuticals, Inc. (Arena) to advance …

Image source: The Motley Fool. Arena Pharmaceuticals, inc (NASDAQ:ARNA) Q2 2021 … gentlemen, and welcome to the Arena Pharmaceuticals Second Quarter 2021 Update. At … , our Executive Vice President and Chief Financial Officer; Doug Manion, our Executive Vice …

… Manmeet S. Soni as Chief Financial Officer (CFO) and Executive Vice President, … Soni served as the CFO of Alnylam Pharmaceuticals where he … Mr. Soni served as CFO at Pharmacyclics where he … member at Pulse Biosciences and Arena Pharmaceuticals.  “I am elated …

→ Pre­ston Klassen has mapped out his next des­ti­na­tion as pres­i­dent and R&D chief of mi­croR­NA de­vel­op­er Reg­u­lus Ther­a­peu­tics. Klassen was the CEO of Metacrine, a biotech co-found­ed and chaired by Rich Hey­man that was en­snarled in …

… source: The Motley Fool. Arena Pharmaceuticals Inc (NASDAQ:ARNA) Q3 2020 … day everyone and welcome to Arena Pharmaceuticals Corporate Conference Call. [Operator … Executive Officer; Laurie Stelzer, our Chief Financial Officer; Dr. Chris Cabell, our Chief …